oxymatrine has been researched along with Fatty Liver, Nonalcoholic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Fei, W; Hu, Z; Huang, X; Liu, X; Ren, L; Yu, X; Zhang, H; Zhen, Y | 1 |
| Chen, S; Huang, W; Li, Y; Ren, L; Song, G; Wang, Y; Yang, L; Zhang, H | 1 |
| Huang, Z; Ji, L; Lu, B; Wei, M; Zhang, S; Zhao, Q | 1 |
| Hu, Z; Shi, L; Song, G; Wang, C; Zhang, D; Zhang, H | 1 |
| Hu, ZJ; Shi, L; Shi, LJ; Song, GY; Wang, C; Zhang, DH; Zhang, HF | 1 |
5 other study(ies) available for oxymatrine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer.
Topics: Animals; Fructose; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Obesity; Proto-Oncogene Proteins c-bcl-2; Rats | 2023 |
Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Topics: Alkaloids; Animals; Body Weight; Diet, High-Fat; Gene Knockdown Techniques; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; MicroRNAs; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Quinolizines; Rats; Rats, Wistar | 2020 |
The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism.
Topics: Alanine Transaminase; Alkaloids; Animals; Cell Line; Diet; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Humans; Liver Cirrhosis; Male; Matrines; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Plant Extracts; Quinolizines; Sophora; Triglycerides; Water | 2020 |
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
Topics: Alkaloids; Animals; Body Weight; Disease Models, Animal; Fatty Liver; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; PPAR alpha; Quinolizines; Rats | 2013 |
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated recep
Topics: Alkaloids; Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Dyslipidemias; Energy Intake; Fatty Acids; Fatty Liver; Fructose; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; PPAR alpha; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2013 |